BC
Bruce & Co Portfolio holdings
AUM
$308M
1-Year Est. Return
16.62%
1 Year Est. Return
+16.62%
AUM
$308M
AUM Growth
-$3.36M
(-1.1%)
Holding
43
Top Sells
| 1 | +$2.08M | |
| 2 | +$792K | |
| 3 | +$465K | |
| 4 |
Darling Ingredients
DAR
|
+$379K |
| 5 |
Fate Therapeutics
FATE
|
+$135K |
Sector Composition
| 1 | Utilities | 25.12% |
| 2 | Healthcare | 24.64% |
| 3 | Industrials | 20.52% |
| 4 | Financials | 9.15% |
| 5 | Communication Services | 6.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Personalis
PSNL
$810M
| $1.66M | 0.54% |
253,000
|
|
||
27
Eli Lilly
LLY
$720B
| $1.56M | 0.51% |
2,000
|
|
||
|
VG
28
Venture Global Inc
VG
$21.6B
| $1.56M | 0.51% |
100,000
|
|
||
29
SiriusXM
SIRI
$7.2B
| $1.28M | 0.42% |
55,784
|
|
||
30
Kodiak Sciences
KOD
$745M
| $1.2M | 0.39% |
323,000
|
|
||
31
Bausch Health
BHC
$2.24B
| $1.14M | 0.37% |
171,000
|
|
||
|
EDAP
32
EDAP TMS
EDAP
$83.8M
| $908K | 0.29% |
553,652
|
|
||
33
Ashland
ASH
$2.23B
| $754K | 0.24% |
15,000
|
|
||
34
MannKind Corp
MNKD
$1.68B
| $730K | 0.24% |
195,073
|
|
||
35
LAVA Therapeutics
LVTX
$38.9M
| $689K | 0.22% |
521,874
|
|
||
36
Viatris
VTRS
$11.9B
| $520K | 0.17% |
58,279
|
|
||
37
908 Devices
MASS
$309M
| $487K | 0.16% |
68,286
|
|
||
|
38
Fate Therapeutics
FATE
$170M
| $481K | 0.16% |
429,188
-120,812
|
|
||
39
WEC Energy
WEC
$37.6B
| $411K | 0.13% |
3,945
|
|
||
40
Caribou Biosciences
CRBU
$245M
| $315K | 0.1% |
250,000
|
|
||
|
IGMS
41
DELISTED
IGM Biosciences
IGMS
| – | – |
-100,000
|
|
||
42
Organon & Co
OGN
$2.41B
| – | – |
-31,200
|
|